OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) - SALIX PHARMACEUTICALS INC ownership

SALIX PHARMACEUTICALS INC's ticker is SLXP and the CUSIP is 795435106. A total of 1 filers reported holding SALIX PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) ownership history of SALIX PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2015$135,870,000,000786,2382.91%
Other shareholders
SALIX PHARMACEUTICALS INC shareholders Q2 2015
NameSharesValueWeighting ↓
MONETARY MANAGEMENT GROUP INC 300$52,0000.02%
View complete list of SALIX PHARMACEUTICALS INC shareholders